Early triple antiretroviral therapy (ART) limits HIV disease progression and improves survival more effectively than early dual or monotherapy in children

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1525, 2006-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early ART therapy best for kids with HIV

By  

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Early antiretroviral treatment worth it in HIV infections

By  

Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Rasagiline monotherapy beneficial in early Parkinson's disease

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Metabolic complications of antiretroviral therapy in HIV-infected children

By Eley Brian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 1, 2008-01 ,pp. : 37-49

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of Antiretroviral Therapy in HIV-1-Infected Children

By Fraaij Pieter L.A.   van Kampen Jeroen J.A.   Burger David M.   Ronald de Groot  

Clinical Pharmacokinetics, Vol. 44, Iss. 9, 2005-01 ,pp. : 935-956

Adis International

Access to resources Recommend Favorite